Mira Sirotic

Director of Investor Relations for Maxwell Biosciences

Mira Sirotic

Mira Sirotic is the Director of Investor Relations & Investor of Maxwell Biosciences, a preclinical stage drug platform company founded in 2016 that is developing a whole new class of patented low molecular weight drug candidates that destroy SARS-CoV-2, the COVID virus, as well as other infectious pathogens including fungal and bacterial pathogens. Maxwell’s first-in-class new drug mimics the natural human immune system antiviral peptides.

Mira’s mission is to help companies, organizations, and people maximize and realize their potential, aiming to make them connect with the right partners and platforms that will lead them to their success.

She is a Certified Management Accountant (CMA). She comes to Maxwell and Keiretsu with over 20 years of experience covering investor relations, business development, marketing & communications, raising capital investment, and financial reporting & analysis.

Mira is also a Vice President and Investor at Keiretsu Forum, founded in 2000 and located in San Francisco, California. Keiretsu Forum is one of the world’s largest angel investment groups, with 60 chapters globally.

Mira’s roles include:

She believes in sharing and creating resources, experiences, opportunities and relationships that can positively impact the lives of others, and this will help to build better communities and organizations.

Mira Sirotic is a member of the Global Investment Leaders Club: “As far as this group goes, one of the things you can gain from GILC is the fact that you’re going to connect with a very strong network of people who will bring you a quality deal flow and companies that hopefully will operate beyond the norms of mainstream. Because of our connections and for myself, as someone who is still part of the deal screening committee within my investor ecosystem, I look for a broad range of sectors to introduce you to other contacts as much as I can. Some folks talked here about logistics, construction, real estate, technology, life sciences, so all of these sectors are of interest to me and while Maxwell is in BioTech, and we fuel the future pharma development, that’s just one hat that I wear. So, I think you will find that folks within the ecosystem of the Global Investment Leaders Club are great connectors.” 

You can have a one-to-one meeting with Mira Sirotic during one of the Club gatherings